Scholarly Index
Suzanne L. Topalian
Bloomberg (United States); 96,597 total citations; 276 total publications; best world rank #43
Bloomberg (United States)
96,597Total citations
276Total publications
101H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cancer Immunotherapy and Biomarkers | Lifetime | 43 | US 26 | 99.87 |
| Immunotherapy and Immune Responses | Lifetime | 92 | US 61 | 99.83 |
| CAR-T cell therapy research | Lifetime | 64 | US 40 | 99.71 |
| Immune Cell Function and Interaction | Lifetime | 460 | US 258 | 99.39 |
| vaccines and immunoinformatics approaches | Lifetime | 205 | US 110 | 97.55 |
| Polyomavirus and related diseases | Lifetime | 392 | US 186 | 96.87 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 990 | US 354 | 96.23 |
| Immunotherapy and Immune Responses | 2021-2025 | 757 | US 244 | 92.18 |
| Polyomavirus and related diseases | 2021-2025 | 266 | US 75 | 87.93 |
| Colorectal and Anal Carcinomas | 2021-2025 | 964 | US 228 | 81.96 |
| Cancer, Stress, Anesthesia, and Immune Response | 2021-2025 | 726 | US 181 | 62.02 |